Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FIRST US BANCSHARES, INC.FUSB · Entity 1337 | Director | August 07, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FIRST US BANCSHARES, INC.
Report date August 07, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 par valueSEC Table I · non-derivative | Direct | 10,850 |
Reported balance
After 2026-08-07 transaction · row 1
1 source rowRow 1 · 2026-08-07 · Purchase · Acquired 245 · Balance 10,850 F1: This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $16.50 to $16.55. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $16.50 to $16.55. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PROASSURANCE CORP
Report date June 26, 2026 · Filed June 26, 2026
Section 16 reporting ended · disclosed 2026-06-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-26 transaction · row 1
1 source rowRow 1 · 2026-06-26 · Disposition to issuer · Disposed 10,621 · Balance 0 F1: On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025 (the "Merger Agreement"), among ProAssurance Corporation (the "Issuer"), The Doctors Company ("Parent") and Jackson Acquisition Corporation, a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. F2: Represents shares awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan ("Deferred Shares"). At the effective time of the Merger ("Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, the Deferred Shares, and any accrued dividend equivalents in such deferred compensation accounts that have been converted into Deferred Shares were converted into the right to receive an amount in cash, without interest, equal to the product of (a) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock") subject to the Deferred Shares immediately prior to the Effective Time, multiplied by (b) the Merger Consideration (as defined below). F3: At the Effective Time, upon the terms and subject to the conditions set forth in the Merger Agreement, each share of Common Stock that was issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive $25.00 per share in cash, without interest, and subject to any applicable withholding taxes (the "Merger Consideration"). |
Filing footnotes · ownership attribution and instrument terms
F1: On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025 (the "Merger Agreement"), among ProAssurance Corporation (the "Issuer"), The Doctors Company ("Parent") and Jackson Acquisition Corporation, a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent.
F2: Represents shares awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan ("Deferred Shares"). At the effective time of the Merger ("Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, the Deferred Shares, and any accrued dividend equivalents in such deferred compensation accounts that have been converted into Deferred Shares were converted into the right to receive an amount in cash, without interest, equal to the product of (a) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock") subject to the Deferred Shares immediately prior to the Effective Time, multiplied by (b) the Merger Consideration (as defined below).
F3: At the Effective Time, upon the terms and subject to the conditions set forth in the Merger Agreement, each share of Common Stock that was issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive $25.00 per share in cash, without interest, and subject to any applicable withholding taxes (the "Merger Consideration").
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2026 Filed Aug 7, 2026 20:44 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 245 | $16.51 | $4,044.95 |
DisclosureSEC source: 0001193125-26-340412 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,850 F1 · price: This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $16.50 to $16.55. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 14:41 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 619 | $16.48 | $10,201.12 |
DisclosureSEC source: 0001193125-26-334191 · ownership.xml · nonDerivative · entry 2 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,605 F2 · price: This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $16.15 to $16.76 Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 14:41 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 136 | $16.53 | $2,248.08 |
DisclosureSEC source: 0001193125-26-334191 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,986 F1 · price: This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $16.50 to $16.60. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 26, 2026 Filed Jun 26, 2026 16:21 UTC | PROASSURANCE CORP PRA · Entity 35239 | Disposition to issuerCommon Stock | 10,621 | $25.00 | $265,525.00 |
DisclosureSEC source: 0002021067-26-000002 · wk-form4_1782490862.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025 (the "Merger Agreement"), among ProAssurance Corporation (the "Issuer"), The Doctors Company ("Parent") and Jackson Acquisition Corporation, a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. F2 · shares: Represents shares awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan ("Deferred Shares"). At the effective time of the Merger ("Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, the Deferred Shares, and any accrued dividend equivalents in such deferred compensation accounts that have been converted into Deferred Shares were converted into the right to receive an amount in cash, without interest, equal to the product of (a) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock") subject to the Deferred Shares immediately prior to the Effective Time, multiplied by (b) the Merger Consideration (as defined below). F3 · price: At the Effective Time, upon the terms and subject to the conditions set forth in the Merger Agreement, each share of Common Stock that was issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive $25.00 per share in cash, without interest, and subject to any applicable withholding taxes (the "Merger Consideration"). Read SEC document |
| February 09, 2026 Filed Feb 10, 2026 19:58 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | GrantCommon Stock, $.01 par value | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-044429 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,850 F1 · shares: Represents shares of time-based restricted stock granted under the First US Bancshares, Inc. 2023 Incentive Plan that will vest in full on the first anniversary of the grant date. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 22:53 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 750 | $13.74 | $10,305.00 |
DisclosureSEC source: 0001193125-25-308283 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,850 Read SEC document |
| November 21, 2025 Filed Nov 21, 2025 21:39 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 250 | $13.83 | $3,457.50 |
DisclosureSEC source: 0001193125-25-291494 · ownership.xml · nonDerivative · entry 3 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,100 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:39 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 250 | $13.65 | $3,412.50 |
DisclosureSEC source: 0001193125-25-291494 · ownership.xml · nonDerivative · entry 2 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,850 Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:39 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 200 | $13.51 | $2,702.00 |
DisclosureSEC source: 0001193125-25-291494 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,600 Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 13:58 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 300 | $13.40 | $4,020.00 |
DisclosureSEC source: 0001193125-25-287105 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,400 Read SEC document |
| November 14, 2025 Filed Nov 14, 2025 22:47 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 500 | $13.43 | $6,715.00 |
DisclosureSEC source: 0001193125-25-283386 · ownership.xml · nonDerivative · entry 2 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,100 F2 · price: This price represents the weighted average sale price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $13.40 to $13.4499. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 22:47 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 500 | $13.72 | $6,860.00 |
DisclosureSEC source: 0001193125-25-283386 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,600 F1 · price: This price represents the weighted average sale price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $13.7094 to $13.738599. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 26, 2025 Filed Aug 26, 2025 21:49 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 1,000 | $11.58 | $11,580.00 |
DisclosureSEC source: 0000950170-25-111501 · ownership.xml · nonDerivative · entry 2 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,100 Read SEC document |
| August 26, 2025 Filed Aug 26, 2025 21:49 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 500 | $11.81 | $5,905.00 |
DisclosureSEC source: 0000950170-25-111501 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,100 Read SEC document |
| August 22, 2025 Filed Aug 25, 2025 21:36 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | PurchaseCommon Stock, $.01 par value | 500 | $11.80 | $5,900.00 |
DisclosureSEC source: 0000950170-25-111254 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,600 Read SEC document |
| May 21, 2025 Filed May 21, 2025 21:05 UTC | PROASSURANCE CORP PRA · Entity 35239 | GrantCommon Stock | 4,101 | $23.16 | $94,979.16 |
DisclosureSEC source: 0001704084-25-000026 · wk-form4_1747861495.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,621 F1 · kind: These shares are awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan and are exempt under Rule 16b-3. This grant was recommended by the Compensation Committee, which is composed entirely of independent directors (as disclosed on page 14 of our 2025 Proxy Statement) and was approved by our Board of Directors at its meeting on May 21, 2025. This year, the recommended and approved stock compensation grant was for shares having a value not to exceed $95,000. The number of whole shares was determined using the closing price of a share of stock on the New York Stock Exchange (NYSE) on the day of the Board of Directors meeting following the Annual Meeting of Shareholders. The NYSE closing price on May 21, 2025 was $23.16, resulting in a distribution to each non-management director of 4,101 shares. Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 23:01 UTC | FIRST US BANCSHARES, INC. FUSB · Entity 1337 | GrantCommon Stock, $.01 par value | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-018147 · ownership.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 F1 · shares: Represents shares of time-based restricted stock granted under the First US Bancshares, Inc. 2023 Incentive Plan that will vest in full on the first anniversary of the grant date. Read SEC document |
| May 23, 2024 Filed May 23, 2024 21:30 UTC | PROASSURANCE CORP PRA · Entity 35239 | GrantCommon Stock | 6,520 | $14.57 | $94,996.40 |
DisclosureSEC source: 0001704084-24-000064 · wk-form4_1716499810.xml · nonDerivative · entry 1 Pierce Staci · CIK 0002021067 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,520 F1 · kind: These shares are awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan and are exempt under Rule 16b-3. This grant was recommended by the Compensation Committee, which is composed entirely of independent directors (as disclosed on page 12 of our 2024 Proxy Statement) and was approved by our Board of Directors at its meeting on May 22, 2024. This year, the recommended and approved stock compensation grant was for shares having a value not to exceed $95,000. The number of whole shares was determined using the closing price of a share of stock on the New York Stock Exchange (NYSE) on the day following the Board of Directors meeting following the Annual Meeting of Shareholders. The NYSE closing price on May 23, 2024 was $14.57, resulting in a distribution to each non-management director of 6,520 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.